{
  "report_rows": [
    {
      "kpi": "Q2 2026 net revenue",
      "prediction": "BEAT",
      "answer": "pred ~$9.18B vs. cons $9.07B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.89 vs. cons $4.77",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 cross-border volume growth",
      "prediction": "IN-LINE",
      "answer": "pred ~11.0% vs. cons 11.0%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Currency-neutral net revenue growth",
      "prediction": "LOWER",
      "answer": "guide ~11.0% vs. cons 11.3% (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Currency-neutral net revenue growth",
      "prediction": "BETTER",
      "answer": "guide ~11.5% vs. cons 11.4% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.6,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.4,
  "day5_path": "FADE",
  "day5_rationale": "The Q2 revenue and EPS beats should support the initial move, but guide ~11.0% versus consensus 11.3% Q3 currency-neutral revenue growth implies softer out-period math; estimate revisions should therefore capture only part of the day-1 gain despite FY2026 guidance of ~11.5% versus consensus 11.4%.",
  "day5_confidence": "MEDIUM"
}